Personalis, Inc. (NASDAQ:PSNL) CFO Sells $12,089.52 in Stock

Personalis, Inc. (NASDAQ:PSNLGet Rating) CFO Aaron Tachibana sold 3,474 shares of the firm’s stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $3.48, for a total value of $12,089.52. Following the completion of the sale, the chief financial officer now owns 223,669 shares in the company, valued at $778,368.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Personalis Trading Down 4.0 %

NASDAQ:PSNL traded down $0.13 during mid-day trading on Thursday, reaching $3.08. 403,254 shares of the stock were exchanged, compared to its average volume of 522,703. The business has a fifty day moving average price of $3.91 and a 200 day moving average price of $5.07. The firm has a market capitalization of $141.43 million, a PE ratio of -1.47 and a beta of 1.64. Personalis, Inc. has a 1-year low of $3.00 and a 1-year high of $21.69.

Personalis (NASDAQ:PSNLGet Rating) last released its earnings results on Wednesday, August 3rd. The company reported ($0.60) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.63) by $0.03. The firm had revenue of $18.24 million for the quarter, compared to analyst estimates of $15.06 million. Personalis had a negative return on equity of 31.55% and a negative net margin of 122.53%. On average, sell-side analysts forecast that Personalis, Inc. will post -2.48 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PSNL has been the topic of a number of research analyst reports. BTIG Research lowered their price target on Personalis to $11.00 in a report on Tuesday, August 9th. HC Wainwright lowered their price target on Personalis from $30.00 to $26.00 and set a “buy” rating on the stock in a report on Thursday, August 4th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Personalis currently has an average rating of “Moderate Buy” and an average price target of $20.50.

Hedge Funds Weigh In On Personalis

Institutional investors have recently bought and sold shares of the stock. Prelude Capital Management LLC purchased a new position in Personalis in the 2nd quarter worth about $35,000. Amalgamated Bank purchased a new position in Personalis in the 1st quarter worth about $37,000. Laurion Capital Management LP purchased a new position in Personalis in the 2nd quarter worth about $45,000. Quantbot Technologies LP increased its stake in Personalis by 168.3% in the 1st quarter. Quantbot Technologies LP now owns 9,293 shares of the company’s stock worth $76,000 after purchasing an additional 5,829 shares in the last quarter. Finally, Harvest Management LLC purchased a new position in Personalis in the 1st quarter worth about $82,000. Hedge funds and other institutional investors own 62.19% of the company’s stock.

About Personalis

(Get Rating)

Personalis, Inc operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities.

Further Reading

Insider Buying and Selling by Quarter for Personalis (NASDAQ:PSNL)

Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter.